VT02956 is a LATS inhibitor ( IC 50 : 0.76 nM for LATS1, 0.52 nM for LATS2). VT02956 targets the Hippo pathway. VT02956 inhibits ESR1 expression and growth of ER+ breast cancer cell lines and patient-derived tumor organoids .
Molecular Weight:
373.45
Formula:
C22H23N5O
* VAT and and shipping costs not included. Errors and price changes excepted
